The efficacy of artificial pulmonary ventilation in acute respiratory failure in patients with hemoblastoses

Gorelov, V.G.; Gorodetskiĭ, V.M.; Shulutko, E.M.; Zil'ber, K.I.

Terapevticheskii Arkhiv 66(7): 17-20

1994


ISSN/ISBN: 0040-3660
PMID: 7985121
Document Number: 431925
The authors review pulmonary effects achieved for 3 years in hemoblastosis patients subjected to artificial lung ventilation (ALV). Out of 44 patients treated the response to ALV was obtained in 7 (16%). Prior to ALV, two of them had granulocyte count under 0.5 x 10(-9)/1. ALV was discontinued in them after recovery of normal granulocyte count. Three patients (7%) survived 6 months and longer. Problems of differential diagnosis in different variants of acute respiratory failure in hemoblastosis patients and ALV potentialities are discussed.

Document emailed within 1 workday
Secure & encrypted payments